diabetestalk.net

Diabetologia Journal Impact Factor

Cardiovascular Diabetology

Cardiovascular Diabetology

Cardiovascular Diabetology celebrates its 15th anniversary Fifteen years ago,professorsAlexander TenenbaumandEnrique Fismanconceivedthe idea of creatinga scientific journal specifically dedicated to exploring the intersection of diabetes and heart disease.Following their initiative, the journalCardiovascular Diabetologywas launched in April 2002. Since then,Cardiovascular Diabetologyhas been growing rapidly,and fortunately became a prestigious international journal that has published more than 1250 scientific articles - some of them representing a major breakthrough in their particular fields. The journal is privileged to havea high-statusEditorial Board, arigorous peer review policy, a multidisciplinary audience, high visibility, and ample global exposure. Authors: Xiao-min Chen, Wen-qiang Zhang, Yuan Tian, Li-fen Wang, Chan-chan Chen and Chuan-mei Qiu Authors: Kevin M. Pantalone, Anita D. Misra-Hebert, Todd M. Hobbs, Xinge Ji, Sheldon X. Kong, Alex Milinovich, Wayne Weng, Janine Bauman, Rahul Ganguly, Bartolome Burguera, Michael W. Kattan and Robert S. Zimmerman Authors: Tatsuya Fukuda, Ryotaro Bouchi, Takato Takeuchi, Kazutaka Tsujimoto, Isao Minami, Takanobu Yoshimoto and Yoshihiro Ogawa Authors: Concetta Irace, Francesco Casciaro, Faustina Barbara Scavelli, Rosa Oliverio, Antonio Cutruzzol, Claudio Cortese and Agostino Gnasso Authors: Tommy Jnsson, Yvonne Granfeldt, Bo Ahrn, Ulla-Carin Branell, Gunvor Plsson, Anita Hansson, Margareta Sderstrm and Staffan Lindeberg Authors: Almudena Gmez-Hernndez, Liliana Perdomo, Natalia de las Heras, Nuria Beneit, scar Escribano, Yolanda F Otero, Carlos Guilln, Sabela Daz-Castroverde, Beatriz Gozalbo-Lpez, Victoria Cachofeiro, Vicente Lahera and Manuel Benito Authors: Bernard Zinman, Silvio E Inzucchi, John M Lachin, Christoph Wa Continue reading >>

Type 2 Diabetes Research Yield, 1951-2012: Bibliometrics Analysis And Density-equalizing Mapping

Type 2 Diabetes Research Yield, 1951-2012: Bibliometrics Analysis And Density-equalizing Mapping

Type 2 Diabetes Research Yield, 1951-2012: Bibliometrics Analysis and Density-Equalizing Mapping Affiliation Department of Epidemiology and Public Health, University College Cork, Cork, Ireland Affiliation Charit-Universittsmedizin Berlin, Free University Berlin and Humboldt-University Berlin, Berlin, Germany Affiliation Department of Epidemiology and Public Health, University College Cork, Cork, Ireland Affiliation Department of Public Health, HSE Eastern Region, Dr Steevens' Hospital, Dublin 8, Ireland Affiliation Department of Epidemiology and Public Health, University College Cork, Cork, Ireland Type 2 Diabetes Research Yield, 1951-2012: Bibliometrics Analysis and Density-Equalizing Mapping The objective of this paper is to provide a detailed evaluation of type 2 diabetes mellitus research output from 1951-2012, using large-scale data analysis, bibliometric indicators and density-equalizing mapping. Data were retrieved from the Science Citation Index Expanded database, one of the seven curated databases within Web of Science. Using Boolean operators "OR", "AND" and "NOT", a search strategy was developed to estimate the total number of published items. Only studies with an English abstract were eligible. Type 1 diabetes and gestational diabetes items were excluded. Specific software developed for the database analysed the data. Information including titles, authors affiliations and publication years were extracted from all files and exported to excel. Density-equalizing mapping was conducted as described by Groenberg-Kloft et al, 2008. A total of 24,783 items were published and cited 476,002 times. The greatest number of outputs were published in 2010 (n=2,139). The United States contributed 28.8% to the overall output, followed by the United Kingdom (8.2%) and Japa Continue reading >>

Statins And Diabetes

Statins And Diabetes

A paper published in the journal Diabetologiahas attempted to analyse the effect of taking statins on incidence of type 2 diabetes in men, reportinga small increase in absolute risk.This analysis was accompanied by roundup comments . Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort Studys main claims and are they supported by the data This study provides evidence for an association between the use of statins and the risk of diabetes but presents what is almost certainly an over-estimate of the association. The paper does not establish a causal link. From the results presented it cannot be concluded that treatment with statins reduces insulin sensitivity and insulin secretion since the analysis done on these outcomes is flawed. Because individuals were already taking statins at baseline it is not possible to disentangle the effect of statins from the effect of confounding by indication (see Limitations for details). This was a large population-based study, which collected information on many of the key confounding factors. Unfortunately, the authors have not taken account of all the confounders in their analysis. In observational studies of drugs, a critical issue is confounding by indication. Statins are prescribed for reducing cholesterol (in order to reduce the risk of cardiovascular disease CVD) and those at high risk of developing CVD are also at high risk of developing diabetes. Therefore, anyone prescribed a statin is likely to already have a higher risk of developing diabetes. The results shown in this paper indicate that this is indeed the case since, at baseline, individuals on statins had higher levels of HbA1c and 2 hour glucose, and had lower Continue reading >>

Diabetes Increases The Risk Of Cancer, With A Higher Risk In Women

Diabetes Increases The Risk Of Cancer, With A Higher Risk In Women

Diabetes increases the risk of cancer, with a higher risk in women Diabetes is a risk factor for all-site cancer for both men and women, but the increased risk is higher in women than in men, according to a new article in Diabetologia (the journal of the European Association for the Study of Diabetes). Cancer is the second leading cause of death in the world. It is estimated that 1 in 4 women, and 1 in 3 men, develop cancer during their lifetime. In 2015 there were 17.5 million incident cancer cases and 8.7 million cancer deaths globally, and these figures are expected to increase in the next decades. Diabetes prevalence has also grown rapidly: 415 million adults were reported to have the condition in 2015, with 5 million deaths attributed. In the same year 12% of global health expenditure was spent on diabetes and its complications. Previous studies have indicated that diabetes is associated with a risk of all-site and some site-specific cancers. For other conditions, such as stroke, coronary heart disease and dementia, there is published evidence (from these same authors) that excess risk of these conditions associated with diabetes is greater in women than in men. This study, conducted by Dr Toshiaki Ohkuma, Dr Sanne Peters and Professor Mark Woodward of the George Institute for Global Health at the University of New South Wales, Sydney, Australia and the University of Oxford, Oxford, UK, assessed whether there are sex differences in the association between diabetes and cancer. In December 2016, the authors undertook a systematic search in PubMed MEDLINE to identify reports on the links between diabetes and cancer. Additional reports were identified from the reference lists of the relevant studies. Only those cohort studies providing relative risks (RRs) for the ass Continue reading >>

Suppression Of Hyperinsulinaemia In Growing Female Mice Provides Long-term Protection Against Obesity

Suppression Of Hyperinsulinaemia In Growing Female Mice Provides Long-term Protection Against Obesity

Suppression of hyperinsulinaemia in growing female mice provides long-term protection against obesity We are experimenting with display styles that make it easier to read articles in PMC. The ePub format uses eBook readers, which have several "ease of reading" features already built in. The ePub format is best viewed in the iBooks reader. You may notice problems with the display of certain parts of an article in other eReaders. Generating an ePub file may take a long time, please be patient. Suppression of hyperinsulinaemia in growing female mice provides long-term protection against obesity Nicole M. Templeman, Susanne M. Clee, and James D. Johnson Hyperinsulinaemia is associated with obesity but its causal role in the onset of obesity remains controversial. In this study, we tested the hypothesis that transient attenuation of diet-induced insulin hypersecretion in young mice can provide sustained protection against obesity throughout adult life. Using genetically humanised mice lacking both alleles of rodent-specific Ins1, we compared mice heterozygous for the ancestral insulin gene Ins2 with Ins2+/+ controls. Female Ins1/:Ins2+/ and Ins1/:Ins2+/+ littermates were fed chow or high-fat diet (HFD). Insulin secretion, metabolic health variables and body mass/composition were tracked for over 1year. We examined islet function and adipose transcript levels of adipogenic, lipogenic and lipolytic genes at two time points. In control Ins1/:Ins2+/+ mice, HFD resulted in elevated fasting and glucose-stimulated insulin secretion between 8weeks and 27weeks of age. Hyperinsulinaemia was reduced by nearly 50% in Ins1/:Ins2+/ mice during this period, without lasting adverse effects on glucose homeostasis. This corresponded with attenuated weight gain and adiposity. White adipose ti Continue reading >>

Journal Of Metabolic Syndrome Open Access

Journal Of Metabolic Syndrome Open Access

Metabolic syndrome is a Group of conditions increased blood pressure, a high blood sugar level, excess body fat around the waist and abnormal cholesterol levels that occur together, increasing your risk of heart disease, stroke and diabetes. Most of the disorders associated with metabolic syndrome have no symptoms, although a large waist circumference is a visible sign. If your blood sugar is very high, you might experience signs and symptoms of diabetes including increased thirst and urination, fatigue, and blurred vision. Endocrinology & Metabolic Syndrome ,Metabolomics: Open Access, Journal of Diabetes Medication & Care, Journal of Diabetes & Metabolism , Endocrine Reviews, Trends in Endocrinology and Metabolism,Diabetes Care, Diabetes, Obesity Reviews,Journal of Bone and Mineral Research, Diabetologia, Nature Reviews Endocrinology, Journal of Clinical Endocrinology and Metabolism, Cytokine and Growth Factor Reviews. Single X syndrome, where an individual has a single X chromosome, typically described as Turner syndrome.The unidentifiable rare disease (named " Syndrome X " by her physicians) that afflicted Brooke Greenberg and only about half a dozen other people in the world, none of whom have aged mentally or physically since young childhood, despite living for years or decades. The underlying disorder causing the syndrome remains unknown, unexplained, and virtually undiscovered. Journal of Diabetic Complications & Medicine ,Endocrinology & Metabolic Syndrome, Diabetes Case Reports, Advanced Techniques in Biology & Medicine,The Lancet Diabetes and Endocrinology, Diabetes, Obesity and Metabolism, International Journal of Obesity , Psycho neuroendocrinology, Current Opinion in Lipidology, Endocrine-Related Cancer. Metabolic disease, any of the diseases or disorders Continue reading >>

Early Menopause Is Independently Linked To An Increased Risk Of Developing Type 2 Diabetes

Early Menopause Is Independently Linked To An Increased Risk Of Developing Type 2 Diabetes

Follow all of ScienceDaily's latest research news and top science headlines ! Early menopause is independently linked to an increased risk of developing type 2 diabetes Women with early or normal onset menopause are at a higher risk of developing type 2 diabetes than those with late onset menopause, concludes new research. Women with early or normal onset menopause are at a higher risk of developing type 2 diabetes than those with late onset menopause, concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes). Previous research (by the same authors of this new study) has shown that women with early onset of menopause (age below 45 years) have an increased risk of cardiovascular disease (CVD) and overall mortality, whereas an onset of menopause at age 50-54 years is linked to a reduced risk of CVD and mortality. While the increased risk is thought to be due to the adverse effects of menopause on CVD risk factors, the influence of age at menopause on these risk factors remains uncertain. Type 2 diabetes (T2D) is a major risk factor for CVD, but it remains unclear whether age at menopause is associated with a risk of T2D. This study, conducted by Dr Taulant Muka and Dr Eralda Asllanaj, of the Department of Epidemiology, Erasmus University Medical Centre, Netherlands, with colleagues, studied the association between age at natural menopause (ANM) and the risk of T2D, and assesses the effects of potential intermediate risk factors in this association. The authors used data obtained via the Rotterdam Study -- a population-based, prospective cohort study carried out in the Ommoord district of Rotterdam, the Netherlands. Participants were aged 45 and over and had examinations every 3 to 5 years. Of a total of 6816 part Continue reading >>

Diabetologia 6.023diabetologia/diabetologia Impact Factor(if)

Diabetologia 6.023diabetologia/diabetologia Impact Factor(if)

Author: Zhao S, Li T, Li J, Lu Q, Han C, Wang N, Qiu Q, Cao H, Xu X, Chen H, Zheng Z. Journal: Diabetologia. 2016 Mar;59(3):644-54. doi: 10.1007/s00125-015-3832-0. Epub 2015 Dec 19. Author: Cavelti-Weder C, Li W, Zumsteg A, Stemann-Andersen M, Zhang Y, Yamada T, Wang M, Lu J, Jermendy A, Bee YM, Bonner-Weir S, Weir GC, Zhou Q. Journal: Diabetologia. 2016 Mar;59(3):522-32. doi: 10.1007/s00125-015-3838-7. Epub 2015 Dec 23. Author: Huo L, Harding JL, Peeters A, Shaw JE, Magliano DJ. Journal: Diabetologia. 2016 Jun;59(6):1177-85. doi: 10.1007/s00125-015-3857-4. Epub 2016 Jan 21. Author: Xu F, Lin B, Zheng X, Chen Z, Cao H, Xu H, Liang H, Weng J. Journal: Diabetologia. 2016 May;59(5):1059-69. doi: 10.1007/s00125-016-3896-5. Epub 2016 Feb 29. Author: Lu H, Hao L, Li S, Lin S, Lv L, Chen Y, Cui H, Zi T, Chu X, Na L, Sun C. Journal: Diabetologia. 2016 Jun;59(6):1247-57. doi: 10.1007/s00125-016-3900-0. Epub 2016 Mar 11. Author: Feng L, Luo H, Xu Z, Yang Z, Du G, Zhang Y, Yu L, Hu K, Zhu W, Tong Q, Chen K, Guo F, Huang C, Li Y. Journal: Diabetologia. 2016 Jun;59(6):1276-86. doi: 10.1007/s00125-016-3912-9. Epub 2016 Mar 16. Author: Wang X, Feng Z, Wang X, Yang L, Han S, Cao K, Xu J, Zhao L, Zhang Y, Liu J. Journal: Diabetologia. 2016 Jun;59(6):1287-96. doi: 10.1007/s00125-016-3919-2. Epub 2016 Mar 18. Author: Yan C, Chen J, Li M, Xuan W, Su D, You H, Huang Y, Chen N, Liang X. Journal: Diabetologia. 2016 Jul;59(7):1524-32. doi: 10.1007/s00125-016-3932-5. Epub 2016 Mar 22. Author: Yan J, Peng D, Jiang F, Zhang R, Chen M, Wang T, Yan D, Wang S, Hou X, Bao Y, Hu C, Jia W. Journal: Diabetologia. 2016 Jul;59(7):1458-62. doi: 10.1007/s00125-016-3939-y. Epub 2016 Mar 23. Author: Chou IC, Wang CH, Lin WD, Tsai FJ, Lin CC, Kao CH. Journal: Diabetologia. 2016 Jun;59(6):1196-203. doi: 10.100 Continue reading >>

Diabetologia May 2017 Issue Now Available

Diabetologia May 2017 Issue Now Available

Diabetologia May 2017 issue now available 30 April 2017 (07:08 PM) - Medical Journals The May 2017 content of Diabetologia, the official journal of EASD is now available. Below you will find a link to the full content, and an abstract of open access articles selected by the editor, Sally Marshall. The whole table of contents can be found here Melatonin signalling and type 2 diabetes risk: is it a case of too little or too much? by Commentaries by: Amlie Bonnefond, Philippe Froguel; Hindrik Mulder Sweet dreams or nightmares? Human genetics provides a powerful tool for identifying causal pathways and relationships of disease risk. In the field, it is well recognised that genetic variation in and near MTNR1B influences type 2 diabetes risk but finding consensus on the molecular mechanisms that bring about this effect is still an area of hot debate and current research activity. In this issue, we feature a review by Forrestel et al (DOI 10.1007/s00125-016-4175-1; see below), summarising our current knowledge of melatonin in diabetes. In addition, because this is currently such a controversial field, we have commissioned two articles from laboratories that are leading research to understand the role of genetic variation in the melatonin receptor in diabetes risk: Bonnefond and Froguel (DOI 10.1007/s00125-017-4255-x) make a case for the detrimental impact of too little melatonin signalling on type 2 diabetes risk, whilst Hindrik Mulder (DOI 10.1007/s00125-017-4249-8) outlines evidence for the negative effect of both elevated and reduced melatonin signalling on diabetes risk. These authors present their opinions on the interpretation of the current landscape and thoughts on how the field might resolve them. [Text supplied by the authors.] Chronomedicine and type 2 diabetes: s Continue reading >>

Diabetologia

Diabetologia

Diabetologia publishes original clinical and experimental research within the field of diabetes. We are interested in papers that convey new information or insight into any aspect of the condition, ranging from basic science to clinical applications. These are judged in terms of their scientific quality, novelty, relevance and interest to our broadly based readership.Diabetologia also hosts editorials, commentaries, debates and reviews, relating to any aspect of diabetes and related conditions, and welcomes submissions from any part of the world. The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third highest values and Q4 (red) the lowest values. The SJR is a size-independent prestige indicator that ranks journals by their 'average prestige per article'. It is based on the idea that 'all citations are not created equal'. SJR is a measure of scientific influence of journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from It measures the scientific influence of the average article in a journal, it expresses how central to the global scientific discussion an average article of the journal is. Continue reading >>

Yoga- A Potential Solution For Diabetes & Metabolic Syndrome Naik D, Thomas N - Indian J Med Res

Yoga- A Potential Solution For Diabetes & Metabolic Syndrome Naik D, Thomas N - Indian J Med Res

Naik D, Thomas N. Yoga- a potential solution for diabetes & metabolic syndrome. Indian J Med Res 2015;141:753-6 Naik D, Thomas N. Yoga- a potential solution for diabetes & metabolic syndrome. Indian J Med Res [serial online] 2015 [cited2018 Sep 11];141:753-6. Available from: India accounts for almost 70 million people with diabetes and the number is expected to increase to 90 million by the year 2030 [1] . Over the last few decades, the mean age of onset of diabetes has been on the decline, the disorder thereby affects a relatively younger segment of the population [2] . Genetic predisposition and environmental factors like physical inactivity, excessive calorie intake and obesity, low birth weight and genetic factors play an important role in the evolution of diabetes [3] , [4] . Visceral adiposity produces several inflammatory cytokines like tumour necrosis factor- (TNF-), interleukin-6 (IL-6), resistin and vistafin which are associated with insulin resistance and the metabolic syndrome [5] . Vitamin D deficiency has been found to be more common among those with prediabetes, diabetes and obesity. The lowered serum circulating vitamin D levels are inversely associated with severity of insulin resistance [6] . Vitamin D supplementation has shown to prevent the development of new onset diabetes thereby improving the insulin sensitivity and glycaemic control [7] . Large clinical studies like the United Kingdom Prospective Diabetes Study (UKPDS) [8] , Diabetes Control and Complications Trial Research Group (DCCT) [9] and the Kumamoto study [10] have demonstrated that intensive glycaemic control can significantly reduce microvascular complications, however, may fail to have an impact on reduction of macrovascular complications. The rapid increase in incidence of diabetes a Continue reading >>

Ios Press

Ios Press

The Mediterranean Journal of Nutrition and Metabolism publishes original scientific papers on metabolism, including diabesity and eating disorders; nutrition (epidemiological, basic, clinical and artificial); dietary and nutritional practices and management and their impact on health from prevention to treatment. The journal hosts the proceedings of relevant congresses and presents shorter notices focused on the original character of the Mediterranean nutritional civilisation. In addition, this journal is intended as a platform for scientific debate and knowledge-sharing among students and clinical practitioners, and between them and the broader scientific community, and finally as a tool for promoting and enhancing scientific cooperation. G. Adami, Dipartimento di Discipline Chirurgiche, Universit di Genova, Genoa, Italy A. Albini, Ricerca Oncologica, Polo Scientifico e Tecnologico, IRRCS Multimedica, Milan, Italy M. Arca, Dip. di Clinica e Terapia Medica, Universit di Roma La Sapienza, Rome, Italy N. Battistini, Scienze Tecniche Dietetiche Applicate, Dipartimento di Scienze Igienistiche, Microbiologiche, Facolt di Medicina e Chirurgia, Universit degli Studi di Modena e Reggio Emilia, Modena, Italy R. Belahsen, Training and Research Unit on Nutrition and Food Sciences, Chouaib Doukkali University, School of Sciences, El Jadida, Morocco Y.N. Berner, Geriatric Medicine, Meir Medical Center, Kfar Saba, Tel Aviv, Israel G. Biolo, Clinica Medica, Ospedale di Cattinara,Trieste, Italy G. Bodoky, Dept. of Oncology, St. Laszlo Hospital, Budapest, Hungary M. Bozo, President of the Syrian Society of Pediatric Gastroenterology and Nutrition, Ministry of Health, Damascus, Syria L. Busetto, Clinica Medica, Policlinico Universitario, Padua, Italy E. Capanoglu Guven, Food Engineering Continue reading >>

Original Publication

Original Publication

fasting diagnosticcriteria. Archives of Internal Medicine 161: 397-404. 9. TheDECODE StudyGroup(2001). Glucose tolerance and all-cause mortality. Cardiology Review 18(2) :28-32. 10. TheDECODA studygroup(2002). Cardiovascular risk profile assessment in glucose intolerantAsianindividuals - an evaluation of the World Health Organization two-stepstrategy:The DECODA study (Diabetes Epidemiology: Collaborative Analysis ofDiagnosticCriteria in 11. TheDECODA studygroup(2002). The fasting plasma glucose cut-point predicting a diabetic 2-hOGTTglucose level depends on the phenotype. Diabetes Research and ClinicalPractice55: 35-43. 12. Qiao Q,Pyrl K,Pyrl M, Nissinen A, Lindstrm J, Tilvis R,Tuomilehto J (for theFinnishDECODE sub-population) (2002). Two-hour glucose is a better riskpredictor forincident coronary heart disease and cardiovascular mortality thanfastingglucose. European Heart Journal 23: 1267-1275. 13. TheDECODE StudyGroup(2002). Age, body mass index and glucose tolerance in 11 Europeanpopulation-based surveys. Diabetic Medicine 19; 558-565. 14. TheDECODE StudyGroup(2003). Is the current definition for diabetes relevant to mortalityrisk fromall causes and cardiovascular and non-cardiovascular diseases? DiabetesCare26: 688-696. 15. TheDECODE studygroup(2003). Gender difference in all-cause and cardiovascular mortalityrelated tohyperglycaemia and newly diagnosed diabetes. Diabetologia 46: 608-617. 16. TheDECODE studygroup(2003). Age and sex specific prevalence of diabetes and impairedglucoseregulation in 13 European cohorts. Diabetes Care 26: 61-69. 17. TheDECODA StudyGroup(2003). Age- and sex-specific prevalence of diabetes and impairedglucoseregulation in 11 Asian cohorts. Diabetes Care 26: 1770-1780. 18. Qiao Q,LindstrmJ,Valle T, Tuomilehto J (for the Finnish DECODE su Continue reading >>

Avances En Diabetologa. Revista Oficial De La Sociedad Espaola De Diabetes

Avances En Diabetologa. Revista Oficial De La Sociedad Espaola De Diabetes

1.Unidad de Endocrinologa. Servicio de Medicina Interna. Hospital Arnau de Vilanova. Valencia The impact factor is the average number of citations in a given year to those papers in a journal published in the previous 2 years. It is calculated by the Institute for the Scientific Information, that also it provides other measures as immediacy, cited half-life and citing half-life. The impact factor has advantages such as the simplicity of calculation, transparency, is a value not dependent on the amount of articles, and useful to compare journals and to monitor journal evolution. Nevertheless, it can be manipulated by authors and publishers. Impact factor is increased by augmenting the number of documents that are not source of citations, but are cited, as reviews, technical reports, consensus, etc.There are alternatives to impact factor, for example the five year impact factor, the SCImago Journal Rank, the Eigenfactor and the potential impact factor of the Spanish medical journals. Of these, the best positioned internationally is the Eigenfactor. Correspondencia: J. Girbs Borrs. Unidad de Endocrinologa. Hospital Arnau de Vilanova. Continue reading >>

A Short Form Of The Diabetes Quality Of Life For Youth Questionnaire: Exploratory And Confirmatory Analysis In A Sample Of 2,077 Young People With Type 1 Diabetes Mellitus

A Short Form Of The Diabetes Quality Of Life For Youth Questionnaire: Exploratory And Confirmatory Analysis In A Sample Of 2,077 Young People With Type 1 Diabetes Mellitus

A short form of the Diabetes Quality of Life for Youth questionnaire: Exploratory and confirmatory analysis in a sample of 2,077 young people with type 1 diabetes mellitus Research output: Contribution to journal Journal article Research peer-review A short form of the Diabetes Quality of Life for Youth questionnaire : Exploratory and confirmatory analysis in a sample of 2,077 young people with type 1 diabetes mellitus. / Skinner, T. C.; Hoey, H.; McGee, H. M.; Skovlund, S. E. In: Diabetologia, Vol. 49, No. 4, 01.04.2006, p. 621-628. Research output: Contribution to journal Journal article Research peer-review Skinner, TC, Hoey, H, McGee, HM & Skovlund, SE 2006, 'A short form of the Diabetes Quality of Life for Youth questionnaire: Exploratory and confirmatory analysis in a sample of 2,077 young people with type 1 diabetes mellitus' Diabetologia, vol. 49, no. 4, pp. 621-628. DOI: 10.1007/s00125-005-0124-0 Skinner, T. C., Hoey, H., McGee, H. M., & Skovlund, S. E. (2006). A short form of the Diabetes Quality of Life for Youth questionnaire: Exploratory and confirmatory analysis in a sample of 2,077 young people with type 1 diabetes mellitus. Diabetologia, 49(4), 621-628. DOI: 10.1007/s00125-005-0124-0 Skinner TC, Hoey H, McGee HM, Skovlund SE. A short form of the Diabetes Quality of Life for Youth questionnaire: Exploratory and confirmatory analysis in a sample of 2,077 young people with type 1 diabetes mellitus. Diabetologia. 2006 Apr 1;49(4):621-628. Available from, DOI: 10.1007/s00125-005-0124-0 Skinner, T. C. ; Hoey, H. ; McGee, H. M. ; Skovlund, S. E./ A short form of the Diabetes Quality of Life for Youth questionnaire : Exploratory and confirmatory analysis in a sample of 2,077 young people with type 1 diabetes mellitus. In: Diabetologia. 2006 ; Vol. 49, No. 4. pp Continue reading >>

More in diabetes